Bacterial skin commensals and their role as host guardians

Beneficial Microbes

Volumn 5, Issue 2, 2014, Pages 201-215

  Christensen, G J M ^a   Bruggemann H ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Bacteriocin; Propionibacterium acnes; Propionobacterium spp; Skin microbiota; Staphylococcus epidermidis

Indexed keywords

BACTERIOCIN; PHENOL; SHORT CHAIN FATTY ACID;

BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOFILM; COMMENSAL; FATTY ACID SYNTHESIS; HOST PARASITE INTERACTION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INVASIVE SPECIES; NONHUMAN; PROPIONIBACTERIUM ACNES; REVIEW; SKIN FLORA; SPECIES COMPOSITION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

BACTERIOCIN; PROPIONIBACTERIUM ACNES; PROPIONOBACTERIUM SPP.; SKIN MICROBIOTA; STAPHYLOCOCCUS EPIDERMIDIS;

HUMANS; MICROBIOTA; OPPORTUNISTIC INFECTIONS; PROPIONIBACTERIUM ACNES; SKIN; SKIN DISEASES, BACTERIAL; SKIN PHYSIOLOGICAL PHENOMENA; STAPHYLOCOCCUS EPIDERMIDIS; SYMBIOSIS;

EID: 84897973069     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2012.0062     Document Type: Review

References (115)

1. Alexeyev, O.A., Marklund, I., Shannon, B., Golovleva, I., Olsson, J., Andersson, C., Eriksson, I., Cohen, R. and Elgh, F., 2007. Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. Journal of Clinical Microbiology 45: 3721-3728.
2. Bäckhed, F., 2012. Host responses to the human microbiome. Nutrition Reviews 70: S14-S17.
3. Bastos, M.C., Ceotto, H., Coelho, M.L. and Nascimento, J.S., 2009.Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Current Pharmaceutical Biotechnology10: 38-61.
4. Baum, M. and Breese, M., 1976. Antitumour effect of Corynebacterium parvum. Possible mode of action. British Journal of Cancer 33: 468-473.
5. Bek-Thomsen, M., Lomholt, H.B. and Kilian, M., 2008. Acne is not associated with yet-uncultured bacteria. Journal of Clinical Microbiology 46: 3355-3360.
6. Borelli, C., Merk, K., Schaller, M., Jacob, K., Vogeser, M., Weindl, G., Berger, U. and Plewig, G., 2006. In vivo porphyrin production by P. acnes in untreated acne patients and its modulation by acne treatment. Acta Dermato-Venereologica 86: 316-319.
7. Brüggemann, H., Henne, A., Hoster, F., Liesegang, H., Wiezer, A., Strittmatter, A., Hujer, S., Dürre, P. and Gottschalk, G., 2004. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305: 671-673.
8. Brzuszkiewicz, E., Weiner, J., Wollherr, A., Thurmer, A., Hupeden, J., Lomholt, H.B., Kilian, M., Gottschalk, G., Daniel, R., Mollenkopf, H.J., Meyer, T.F. and Brüggemann, H., 2011. Comparative genomics and transcriptomics of Propionibacterium acnes. PLoS One 6: e21581.
9. Cerca, N., Jefferson, K.K., Oliveira, R., Pier, G.B. and Azeredo, J., 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infection and Immunity 74: 4849-4855.
10. Cervi, L., MacDonald, A.S., Kane, C., Dzierszinski, F. and Pearce, E.J., 2004. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. Journal of Immunology 172: 2016-2020.
11. Cheung, G.Y., Rigby, K., Wang, R., Queck, S.Y., Braughton, K.R., Whitney, A.R., Teintze, M., DeLeo, F.R. and Otto, M., 2010. Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathogens 6: e1001133.
12. Cho, S.H., Naber, K., Hacker, J. and Ziebuhr, W., 2002. Detection of the icaADBC gene cluster and biofilm formation in Staphylococcus epidermidis isolates from catheter-related urinary tract infections. International Journal of Antimicrobial Agents 19: 570-575.
13. Choudhury, T.K., 1978. Synergistic lysis of erythrocytes by Propionibacterium acnes. Journal of Clinical Microbiology 8: 238-241.
14. Coelho, M.A., Sampaio, J.P. and Gonçalves, P., 2013. Living and thriving on the skin: Malassezia genomes tell the story. mBio 4: e00117-13.
15. Cogen, A.L., Yamasaki, K., Muto, J., Sanchez, K.M., Crotty Alexander, L., Tanios, J., Lai, Y., Kim, J.E., Nizet, V. and Gallo, R.L., 2010a. Staphylococcus epidermidis antimicrobial delta-toxin (phenolsoluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS One 5: e8557.
16. Cogen, A.L., Yamasaki, K., Sanchez, K.M., Dorschner, R.A., Lai, Y., MacLeod, D.T., Torpey, J.W., Otto, M., Nizet, V., Kim, J.E. and Gallo, R.L., 2010b. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. Journal of Investigative Dermatology 130: 192-200.
17. Cotter, P.D., Ross, R.P. and Hill, C., 2013. Bacteriocins - a viable alternative to antibiotics? Nature Reviews Microbiology 11: 95-105.
18. Delgado, S., Suarez, A. and Mayo, B., 2011. Identification, typing and characterisation of Propionibacterium strains from healthy mucosa of the human stomach. International Journal of Food Microbiology 149: 65-72.
19. Dessinioti, C. and Katsambas, A.D., 2010. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clinical Dermatology 28: 2-7.
20. Dhople, V.M. and Nagaraj, R., 2005. Conformation and activity of delta-lysin and its analogs. Peptides 26: 217-225.
21. Engelhardt, K., Degnes, K.F. and Zotchev, S.B., 2010. Isolation and characterization of the gene cluster for biosynthesis of the thiopeptide antibiotic TP-1161. Applied and Environmental Microbiology 76: 7093-7101.
22. Fassi Fehri, L., Mak, T.N., Laube, B., Brinkmann, V., Ogilvie, L.A., Mollenkopf, H., Lein, M., Schmidt, T., Meyer, T.F. and Brüggemann, H., 2011. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. International Journal of Medical Microbiology 301: 69-78.
23. Faye, T., Holo, H., Langsrud, T., Nes, I.F. and Brede, D.A., 2011. The unconventional antimicrobial peptides of the classical propionibacteria. Applied Microbiology and Biotechnology 89: 549-554.
24. Fontana, M.B., De Bastos Mdo, C. and Brandelli, A., 2006. Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters. Current Microbiology 52: 350-353.
25. Fujimura, S. and Nakamura, T., 1978. Purification and properties of a bacteriocin-like substance (acnecin) of oral Propionibacterium acnes. Antimicrobial Agents and Chemotherapy 14: 893-898.
26. Furukawa, A., Uchida, K., Ishige, Y., Ishige, I., Kobayashi, I., Takemura, T., Yokoyama, T., Iwai, K., Watanabe, K., Shimizu, S., Ishida, N., Suzuki, Y., Suzuki, T., Yamada, T., Ito, T. and Eishi, Y., 2009. Characterization of Propionibacterium acnes isolates from sarcoid and non-sarcoid tissues with special reference to cell invasiveness, serotype, and trigger factor gene polymorphism. Microbial Pathogenesis 46: 80-87.
27. Gribbon, E.M., Cunliffe, W.J. and Holland, K.T., 1993. Interaction of Propionibacterium acnes with skin lipids in vitro. Journal of General Microbiology 139: 1745-1751.
28. Grice, E.A. and Segre, J.A., 2011. The skin microbiome. Nature Reviews Microbiology 9: 244-253.
29. Grice, E.A. and Segre, J.A., 2012. The human microbiome: our second genome. Annual Review of Genomics and Human Genetics 13: 151-170.
30. Grice, E.A., Kong, H.H., Conlan, S., Deming, C.B., Davis, J., Young, A.C., Bouffard, G.G., Blakesley, R.W., Murray, P.R., Green, E.D., Turner, M.L. and Segre, J.A., 2009. Topographical and temporal diversity of the human skin microbiome. Science 324: 1190-1192.
31. Hajjar, A.M., O'Mahony, D.S., Ozinsky, A., Underhill, D.M., Aderem, A., Klebanoff, S.J. and Wilson, C.B., 2001. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. Journal of Immunology 166: 15-19.
32. Handke, L.D., Conlon, K.M., Slater, S.R., Elbaruni, S., Fitzpatrick, F., Humphreys, H., Giles, W.P., Rupp, M.E., Fey, P.D. and O'Gara, J.P., 2004. Genetic and phenotypic analysis of biofilm phenotypic variation in multiple Staphylococcus epidermidis isolates. Journal of Medical Microbiology 53: 367-374.
33. Heidrich, C., Pag, U., Josten, M., Metzger, J., Jack, R.W., Bierbaum, G., Jung, G. and Sahl, H.G., 1998. Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Applied and Environmental Microbiology 64: 3140-3146.
34. Heng, N.C.K. and Tagg, J.R., 2006. What's in a name? Class distinction for bacteriocins. Nature Reviews Microbiology 4. DOI: http://dx.doi. org/10.1038/nrmicro1273-c1.
35. Heng, N.C.K., Wescombe, P.A., Burton, J.P., Jack, R.W. and Tagg, J.R., 2007. The diversity of bacteriocins in Gram-positive bacteria. In: Riley, M.A. and Chavan, M.A. (eds.) Bacteriocins: ecology and evolution. Springer, New York, NY, USA, pp. 45-92.
36. Holland, C., Mak, T.N., Zimny-Arndt, U., Schmid, M., Meyer, T.F., Jungblut, P.R. and Brüggemann, H., 2010. Proteomic identification of secreted proteins of Propionibacterium acnes. BMC Microbiology 10: 230.
37. Ingham, E., Holland, K.T., Gowland, G. and Cunliffe, W.J., 1979. Purification and partial characterization of hyaluronate lyase (EC 4.2.2.1) from Propionibacterium acnes. Journal of General Microbiology 115: 411-418.
38. Ji, G., 1997. Bacterial interference caused by autoinducing peptide variants. Science 276: 2027-2030.
39. Kalis, C., Gumenscheimer, M., Freudenberg, N., Tchaptchet, S., Fejer, G., Heit, A., Akira, S., Galanos, C. and Freudenberg, M.A., 2005. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. Journal of Immunology 174: 4295-4300.
40. Kamisango, K., Saiki, I., Tanio, Y., Okumura, H., Araki, Y., Sekikawa, I., Azuma, I. and Yamamura, Y., 1982. Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes. Journal of Biochemistry 92: 23-33.
41. Kies, S., Vuong, C., Hille, M., Peschel, A., Meyer, C., Götz, F. and Otto, M., 2003. Control of antimicrobial peptide synthesis by the agr quorum sensing system in Staphylococcus epidermidis: activity of the lantibiotic epidermin is regulated at the level of precursor peptide processing. Peptides 24: 329-338.
42. Kim, J., Ochoa, M.T., Krutzik, S.R., Takeuchi, O., Uematsu, S., Legaspi, A.J., Brightbill, H.D., Holland, D., Cunliffe, W.J., Akira, S., Sieling, P.A., Godowski, P.J. and Modlin, R.L., 2002. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Journal of Immunology 169: 1535-1541.
43. Kitagawa, H., Yamanaka, K., Kakeda, M., Inada, H., Imai, Y., Gabazza, E.C., Kurokawa, I. and Mizutani, H., 2011. Propionibacterium acnes vaccination induces regulatory T cells and Th1 immune responses and improves mouse atopic dermatitis. Experimental Dermatology 20: 157-158.
44. Kocianova, S., Vuong, C., Yao, Y., Voyich, J.M., Fischer, E.R., DeLeo, F.R. and Otto, M., 2005. Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. Journal of Clinical Investigation 115: 688-694.
45. Kogan, G., Sadovskaya, I., Chaignon, P., Chokr, A. and Jabbouri, S., 2006. Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiology Letters 255:11-16.
46. Kozitskaya, S., Cho, S.H., Dietrich, K., Marre, R., Naber, K. and Ziebuhr, W., 2004. The bacterial insertion sequence element IS256 occurs preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilm formation and resistance to aminoglycosides. Infection and Immunity 72: 1210-1215.
47. Kristian, S.A., Birkenstock, T.A., Sauder, U., Mack, D., Götz, F. and Landmann, R., 2008. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. Journal of Infectious Diseases 197: 1028-1035.
48. Lai, Y., Cogen, A.L., Radek, K.A., Park, H.J., Macleod, D.T., Leichtle, A., Ryan, A.F., Di Nardo, A. and Gallo, R.L., 2010. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. Journal of Investigative Dermatology 130: 2211-2221.
49. Lai, Y., Di Nardo, A., Nakatsuji, T., Leichtle, A., Yang, Y., Cogen, A.L., Wu, Z.R., Hooper, L.V., Schmidt, R.R., Von Aulock, S., Radek, K.A., Huang, C.M., Ryan, A.F. and Gallo, R.L., 2009. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nature Medicine 15: 1377-1382.
50. Lai, Y., Villaruz, A.E., Li, M., Cha, D.J., Sturdevant, D.E. and Otto, M., 2007. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Molecular Microbiology 63: 497-506.
51. Li, M., Lai, Y., Villaruz, A.E., Cha, D.J., Sturdevant, D.E. and Otto, M., 2007. Gram-positive three-component antimicrobial peptidesensing system. Proceedings of the National Academy of Sciences of the USA 104: 9469-9474.
52. Liavonchanka, A., Hornung, E., Feussner, I. and Rudolph, M.G., 2006. Structure and mechanism of the Propionibacterium acnes polyunsaturated fatty acid isomerase. Proceedings of the National Academy of Sciences of the USA 103: 2576-2581.
53. Liu, P.F., Nakatsuji, T., Zhu, W., Gallo, R.L. and Huang, C.M., 2011. Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris. Vaccine 29: 3230-3238.
54. Lodes, M.J., Secrist, H., Benson, D.R., Jen, S., Shanebeck, K.D., Guderian, J., Maisonneuve, J.F., Bhatia, A., Persing, D., Patrick, S. and Skeiky, Y.A., 2006. Variable expression of immunoreactive surface proteins of Propionibacterium acnes. Microbiology 152: 3667-3681.
55. Lomholt, H.B. and Kilian, M., 2010. Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS One 5: e12277.
56. Lyon, W.J. and Glatz, B.A., 1993. Isolation and purification of propionicin PLG-1, a bacteriocin produced by a strain of Propionibacterium thoenii. Applied and Environmental Microbiology 59: 83-88.
57. Mack, D., Davies, A.P., Harris, L.G., Knobloch, J.K. and Rohde, H., 2009. Staphylococcus epidermidis biofilms: functional molecules, relation to virulence, and vaccine potential. Topics in Current Chemistry 288:157-182.
58. Mak, T.N., Fischer, N., Laube, B., Brinkmann, V., Metruccio, M.M., Sfanos, K.S., Mollenkopf, H.J., Meyer, T.F. and Brüggemann, H., 2012. Propionibacterium acnes host cell tropism contributes to vimentin-mediated invasion and induction of inflammation. Cellular Microbiology 14: 1720-1733.
59. Mak, T.N., Yu, S.H., De Marzo, A.M., Brüggemann, H. and Sfanos, K.S., 2013. Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens. Prostate 73: 770-777.
60. McDowell, A., Barnard, E., Nagy, I., Gao, A., Tomida, S., Li, H., Eady, A., Cove, J., Nord, C.E. and Patrick, S., 2012. An expanded multilocus sequence typing scheme for Propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. PLoS One 7: e41480.
61. McDowell, A., Gao, A., Barnard, E., Fink, C., Murray, P.I., Dowson, C.G., Nagy, I., Lambert, P.A. and Patrick, S., 2011. A novel multilocus sequence typing scheme for the opportunistic pathogen Propionibacterium acnes and characterization of type I cell surfaceassociated antigens. Microbiology 157: 1990-2003.
62. Mehlin, C., Headley, C.M. and Klebanoff, S.J., 1999. An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. Journal of Experimental Medicine 189: 907-918.
63. Meyer, C., Bierbaum, G., Heidrich, C., Reis, M., Suling, J., Iglesias- Wind, M.I., Kempter, C., Molitor, E. and Sahl, H.G., 1995. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. European Journal of Biochemistry 232: 478-489.
64. Miragaia, M., Thomas, J.C., Couto, I., Enright, M.C. and De Lencastre, H., 2007. Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data. Journal of Bacteriology 189: 2540-2552.
65. Miskin, J.E., Farrell, A.M., Cunliffe, W.J. and Holland, K.T., 1997. Propionibacterium acnes, a resident of lipid-rich human skin, produces a 33 kDa extracellular lipase encoded by gehA. Microbiology 143: 1745-1755.
66. Nagy, I., Pivarcsi, A., Kis, K., Koreck, A., Bodai, L., McDowell, A., Seltmann, H., Patrick, S., Zouboulis, C.C. and Kemény, L., 2006. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes and Infection 8: 2195-2205.
67. Nagy, I., Pivarcsi, A., Koreck, A., Széll, M., Urbán, E. and Kemény, L., 2005. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. Journal of Investigative Dermatology 124:931-938.
68. Nakatsuji, T., Liu, Y.T., Huang, C.P., Zouboulis, C.C., Gallo, R.L. and Huang, C.M., 2008. Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS One 3: e1551.
69. Nakatsuji, T., Tang, D.C., Zhang, L., Gallo, R.L. and Huang, C.M., 2011. Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment. PLoS One 6: e14797.
70. Nascimento, J.S., Ceotto, H., Nascimento, S.B., Giambiagi-Demarval, M., Santos, K.R. and Bastos, M.C., 2006. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains. Letters in Applied Microbiology 42: 215-221.
71. Otto, M., 2008. Staphylococcal biofilms. Current Topics in Microbiology and Immunology 322: 207-228.
72. Otto, M., 2009. Staphylococcus epidermidis--the 'accidental' pathogen. Nature Reviews Microbiology 7: 555-567.
73. Otto, M., 2013. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annual Review of Medicine 64: 175-188.
74. Otto, M., Echner, H., Voelter, W. and Götz, F., 2001. Pheromone crossinhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infection and Immunity 69: 1957-1960.
75. Otto, M., Sussmuth, R., Vuong, C., Jung, G. and Götz, F., 1999. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Letters 450: 257-262.
76. Paul, G.E. and Booth, S.J., 1988. Properties and characteristics of a bacteriocin-like substance produced by Propionibacterium acnes isolated from dental plaque. Canadian Journal of Microbiology 34: 1344-1347.
77. Perego, M., Glaser, P., Minutello, A., Strauch, M.A., Leopold, K. and Fischer, W., 1995. Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. Journal of Biological Chemistry 270: 15598-15606.
78. Perry, A. and Lambert, P., 2011. Propionibacterium acnes: infection beyond the skin. Expert Review of Anti-Infective Therapy 9: 1149-1156.
79. Peschel, A., 2002. How do bacteria resist human antimicrobial peptides? Trends in Microbiology 10: 179-186.
80. Peschel, A., Jack, R.W., Otto, M., Collins, L.V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W.F., Jung, G., Tarkowski, A., Van Kessel, K.P. and Van Strijp, J.A., 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. Journal of Experimental Medicine 193: 1067-1076.
81. Poonam, Pophaly, S.D., Tomar, S.K., De, S. and Singh, R., 2012. Multifaceted attributes of dairy propionibacteria: a review. World Journal of Microbiology and Biotechnology 28: 3081-3095.
82. Pringle, A.T., Cummins, C.S., Bishop, B.F. and Viers, V.S., 1982. Fate of vaccines of Propionibacterium acnes after phagocytosis by murine macrophages. Infection and Immunity 38: 371-374.
83. Rosenthal, M., Goldberg, D., Aiello, A., Larson, E. and Foxman, B., 2011. Skin microbiota: Microbial community structure and its potential association with health and disease. Infection, Genetics and Evolution 11: 839-848.
84. Rupp, M.E. and Archer, G.L., 1994. Coagulase-negative staphylococci: pathogens associated with medical progress. Clinical Infectious Diseases 19: 231-243.
85. Rupp, M.E., Ulphani, J.S., Fey, P.D. and Mack, D., 1999. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheterassociated infection in a rat model. Infection and Immunity 67: 2656-2659.
86. Sahl, H.G. and Bierbaum, G., 1998. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from grampositive bacteria. Annual Review of Microbiology 52: 41-79.
87. Sandiford, S. and Upton, M., 2012. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against staphylococci. Antimicrobial Agents and Chemotherapy 56: 1539-1547.
88. Schaller, M., Loewenstein, M., Borelli, C., Jacob, K., Vogeser, M., Burgdorf, W.H. and Plewig, G., 2005. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. British Journal of Dermatology 153: 66-71.
89. Schnell, N., Entian, K.D., Schneider, U., Gotz, F., Zahner, H., Kellner, R. and Jung, G., 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333: 276-278.
90. Shaheen, B. and Gonzalez, M., 2011. A microbial aetiology of acne: what is the evidence? British Journal of Dermatology 165: 474-485.
91. Sharon, I., Morowitz, M.J., Thomas, B.C., Costello, E.K., Relman, D.A. and Banfield, J.F., 2012. Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Research 23: 111-120.
92. Shinohara, D.B., Vaghasia, A.M., Yu, S.H., Mak, T.N., Brüggemann, H., Nelson, W.G., De Marzo, A.M., Yegnasubramanian, S. and Sfanos, K.S., 2013. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate 73: 1007-1015.
93. Shu, M., Wang, Y., Yu, J., Kuo, S., Coda, A., Jiang, Y., Gallo, R.L. and Huang, C.M., 2013. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One 8: e55380.
94. Sörensen, M., Mak, T.N., Hurwitz, R., Ogilvie, L.A., Mollenkopf, H.J., Meyer, T.F. and Brüggemann, H., 2010. Mutagenesis of Propionibacterium acnes and analysis of two CAMP factor knockout mutants. Journal of Microbiological Methods 83: 211-216.
95. Stevens, N.T., Sadovskaya, I., Jabbouri, S., Sattar, T., O'Gara, J.P., Humphreys, H. and Greene, C.M., 2009. Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2. Cellular Microbiology 11: 421-432.
96. Stucker, M., Pieck, C., Stoerb, C., Niedner, R., Hartung, J. and Altmeyer, P., 2004. Topical vitamin B12-a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial. British Journal of Dermatology 150: 977-983.
97. Sugisaki, H., Yamanaka, K., Kakeda, M., Kitagawa, H., Tanaka, K., Watanabe, K., Gabazza, E.C., Kurokawa, I. and Mizutani, H., 2009. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. Journal of Dermatological Science 55: 47-52.
98. Tchaptchet, S., Kirberg, J., Freudenberg, N., Schamel, W.W., Galanos, C. and Freudenberg, M.A., 2010. Innate, antigen-independent role for T cells in the activation of the immune system by Propionibacterium acnes. European Journal of Immunology 40: 2506-2516.
99. Teufel, P. and Götz, F., 1993. Characterization of an extracellular metalloprotease with elastase activity from Staphylococcus epidermidis. Journal of Bacteriology 175: 4218-4224.
100. Tomida, S., Nguyen, L., Chiu, B.H., Liu, J., Sodergren, E., Weinstock, G.M. and Li, H., 2013. Pan-genome and comparative genome analyses of Propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome. mBbio 4: e00003-13.
101. Valanne, S., McDowell, A., Ramage, G., Tunney, M.M., Einarsson, G.G., O'Hagan, S., Wisdom, G.B., Fairley, D., Bhatia, A., Maisonneuve, J.F., Lodes, M., Persing, D.H. and Patrick, S., 2005. CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. Microbiology 151: 1369-1379.
102. Van de Kamp, M., Van den Hooven, H.W., Konings, R.N., Bierbaum, G., Sahl, H.G., Kuipers, O.P., Siezen, R.J., De Vos, W.M., Hilbers, C.W. and Van de Ven, F.J., 1995. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. European Journal of Biochemistry 230: 587-600.
103. Vuong, C., Durr, M., Carmody, A.B., Peschel, A., Klebanoff, S.J. and Otto, M., 2004b. Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cellular Microbiology 6: 753-759.
104. Vuong, C., Voyich, J.M., Fischer, E.R., Braughton, K.R., Whitney, A.R., DeLeo, F.R. and Otto, M., 2004a. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cellular Microbiology 6: 269-275.
105. Wang, R., Braughton, K.R., Kretschmer, D., Bach, T.H., Queck, S.Y., Li, M., Kennedy, A.D., Dorward, D.W., Klebanoff, S.J., Peschel, A., DeLeo, F.R. and Otto, M., 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine 13: 1510-1514.
106. Wang, R., Khan, B.A., Cheung, G.Y., Bach, T.H., Jameson-Lee, M., Kong, K.F., Queck, S.Y. and Otto, M., 2011. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. Journal of Clinical Investigation 121: 238-248.
107. Wanke, I., Steffen, H., Christ, C., Krismer, B., Götz, F., Peschel, A., Schaller, M. and Schittek, B., 2011. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. Journal of Investigative Dermatology 131: 382-390.
108. Wieland Brown, L.C., Acker, M.G., Clardy, J., Walsh, C.T. and Fischbach, M.A., 2009. Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin. Proceedings of the National Academy of Sciences of the USA 106: 2549-2553.
109. Williams, H.C., Dellavalle, R.P. and Garner, S., 2012. Acne vulgaris. The Lancet 379: 361-372.
110. Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P. and Edmond, M.B., 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 39: 309-317.
111. Yao, Y., Sturdevant, D.E. and Otto, M., 2005. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. Journal of Infectious Diseases 191: 289-298.
112. Yao, Y., Vuong, C., Kocianova, S., Villaruz, A.E., Lai, Y., Sturdevant, D.E. and Otto, M., 2006. Characterization of the Staphylococcus epidermidis accessory-gene regulator response: quorum-sensing regulation of resistance to human innate host defense. Journal of Infectious Diseases 193: 841-848.
113. Zhang, Y.-Q., Ren, S.-X., Li, H.-L., Wang, Y.-X., Fu, G., Yang, J., Qin, Z.-Q., Miao, Y.-G., Wang, W.-Y., Chen, R.-S., Shen, Y., Chen, Z., Yuan, Z.-H., Zhao, G.-P., Qu, D., Danchin, A. and Wen, Y.-M., 2003. Genome-based analysis of virulence genes in a non-biofilmforming Staphylococcus epidermidis strain (ATCC 12228). Molecular Microbiology 49: 1577-1593.
114. Ziebuhr, W., Heilmann, C., Götz, F., Meyer, P., Wilms, K., Straube, E. and Hacker J., 1997. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infection and Immunity 65: 890-896.
115. Ziebuhr, W., Krimmer, V., Rachid, S., Lössner, I., Götz, F. and Hacker, J., 1999. A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Molecular Microbiology 32: 345-356.